Merck & Co., Inc.

MRK · Pharmaceutical Preparations · $362.4B
Powering up
MRK
$146.87
▼ −0.19%
09/18 O 147.08 H 147.84 L 145.74 C 146.87 ▼ −0.19%
Vol 31.2M RS 87
RS rating87
Now vs pivot (%)−6.40%
Tightening (ATR ratio)1.44×
Volume dry-up0.79×
Up/down volume, net0.08
From 52-week high6%
forming
Previous breakout still open ▲ +17.07% in Jun
Powering up
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

The read

The base has run 3.6 weeks and fell 9% from its ceiling at its deepest. The pivot is $156.92, and the stock closed 6.4% below it. Its relative strength rating is 87.

Also on
Peers
Catalyst roadmap
  1. Earningstentativein 41d
    Quarterly earnings
    Oct 29, 2026
  2. EarningstentativeLLY · competitorin 41d
    LLY reports
    Oct 29, 2026
  3. EarningstentativeAAPL · industryin 41d
    AAPL reports
    Oct 29, 2026
Flagged by the market sweep

Nothing flagged for this company on the last market sweep.

In the news
Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. Historical figures are backtests and are hypothetical.

What that means, in full
Merck & Co., Inc. (MRK) — The Tape